Parties d'ouvrages collectifs (12)
  1. 1. Kollmann, T. R., Dauby, N., Harbeson, D. D., Fidanza, M., & Marchant, A. (2021). Host Defense Mechanisms Against Bacteria. In R. Polin, S. Abman, W. Benitz, & D. Rowitch (Eds.), Fetal and Neonatal Physiology. Philadelphia: Elsevier.
  2. 2. Dauby, N., & Marchant, A. (2019). Fetal Infections: Immune Response to Infections during Fetal Life. In Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits (pp. 215-223). Cambridge University Press. doi:10.1017/9781108564434.022
  3. 3. Chu, H. H., & Marchant, A. (2019). Immunobiological aspects of vaccines in pregnancy: Maternal perspective. In Maternal Immunization (pp. 43-65). Elsevier. doi:10.1016/B978-0-12-814582-1.00003-6
  4. 4. Kollmann, T., & Marchant, A. (2017). Host Defense Mechanisms against Bacteria. In Host Defense Mechanisms against Bacteria, Fetal and Neonatal Physiology (5 ed., pp. 1163-1170). Philadelphia: Elsevier.
  5. 5. Huygens, A., & Marchant, A. (2009). Fetal infections: Immune responses to congenital infections. In Fetal Therapy: Scientific Basis and Critical Appraisal of Clinical Benefits (pp. 200-207). Cambridge University Press. doi:10.1017/CBO9780511997778.024
  6. 6. Marchant, A., van der Poll, T., & Goldman, M. (1998). Interleukin-10 and other suppressive cytokines. In H. Brade, S. Opal, & S. Vogel (Eds.), Endotoxin in Health and Disease (pp. 581-590). Marcel Dekker.
  7. 7. Marchant, A., & Goldman, M. (1997). Cytokines et sepsis. In P. Galanaud & D. Emilie (Eds.), Cytokines et médecine interne. Masson.
  8. 8. Marchant, A., Vincent, J. L., & Goldman, M. (1996). Interleukin-10 as a protective cytokine produced during sepsis. In D. Morrison & J. Ryan (Eds.), Novel Therapeutic Strategies in the Treatment of Sepsis (pp. 301-311). New York: Academic Press.
  9. 9. Goldman, M., & Marchant, A. (1996). Regulatory role and pharmacological modulation of interleukin 10 production during septic shock. In J. L. Vincent (Ed.), Yearbook of Intensive Care and Emergency Medicine (pp. 125-130). Berlin: Springer-Verlag.
  10. 10. Marchant, A., Devière, J., Byl, B., De Groote, D., Vincent, J. L., & Goldman, M. (1996). Interleukin-10 as a protective cytokine produced during human septicemia and septic shock. In E. Faist, A. Baue, & E. Schildberg (Eds.), The Immune Consequences of Trauma, Shock and Sepsis: Mechanisms and Therapeutic Approaches, Vol. 1. MOF, MODS and SIRS Basic Mechanisms in Tissue Inflammation and Tissue Injury (pp. 385-388). Lengerich: Pabst Science Publishers.
  11. 11. Marchant, A., Duchow, J., & Goldman, M. (1994). The protective role of interleukin-10 in sepsis. In J. L. Vincent (Ed.), Yearbook of intensive care and emergency medicine (pp. 42-46). Berlin: Springer-Verlag.
  12. 12. Schandené, L., Ferster, A., Mascart, F., Goetghebuer, T., Marchant, A., Velu, T., Sariban, E., & Goldman, M. (1992). Imbalance in the production of interferon-gamma and interleukin-4 in a patient with Ommen's syndrome: rationale for interferon-gamma therapy. In New Advances on Cytokines (pp. 219-225). Raven Press.(Serono symposia publication).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>